{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/immunizations-pneumococcal/","result":{"data":{"firstChapter":{"id":"c2a8d969-5d35-5185-b666-883786b066c5","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 5d818c43-7430-4fc4-88a3-72652f3b1d93 --><h1>Immunizations - pneumococcal: Summary</h1><!-- end field 5d818c43-7430-4fc4-88a3-72652f3b1d93 -->","htmlStringContent":"<!-- begin item 17d9c84b-3c58-4646-b43d-a96560764103 --><!-- begin field b937547e-3c7c-4610-a156-061bb29b52cf --><ul><li>Infection with the encapsulated bacterium <em>Streptococcus pneumoniae </em>causes pneumococcal infection, which may be invasive (for example causing bacteraemic pneumonia, bacteraemia, meningitis) or non-invasive (for example causing otitis media, sinusitis, non-invasive pneumococcal pneumonia, bronchitis).</li><li>There are two types of pneumococcal vaccine available in the UK:<ul><li>PCV13 (Prevenar13<sup>®</sup>) is a 13-valent pneumococcal conjugate vaccine mainly suitable for children aged less than 2 years as part of the Childhood Immunization Programme, or for children aged less than 5 years considered to be at high risk of infection.</li><li>PPV23 (Pneumovax<sup>®</sup>) is a 23-valent pneumococcal polysaccharide vaccine, suitable for older children (aged 2 years and over) and adults.</li></ul></li><li>The following groups of people should receive pneumococcal vaccination:<ul><li>All infants (as part of the Childhood Immunization Programme).</li><li>All people aged 65 years and over.</li><li>All people at high risk of pneumococcal disease.</li></ul></li><li>People at high risk of pneumococcal disease include those with:<ul><li>Asplenia or dysfunction of the spleen.</li><li>Chronic respiratory, heart, kidney, or liver disease.</li><li>Diabetes that is not controlled by diet alone.</li><li>Immunosuppression caused by disease or treatment.</li><li>Cochlear implants.</li><li>Cerebrospinal fluid leaks.</li><li>An occupational risk, such as welders.</li></ul></li><li>Re-vaccination is not recommended for most people. However, for those who have asplenia, splenic dysfunction or chronic kidney disease, re-vaccination is recommended every 5 years.</li><li>The vaccination schedule will depend on the age of the person to be vaccinated, their level of risk, and previous vaccination history.</li></ul><!-- end field b937547e-3c7c-4610-a156-061bb29b52cf --><!-- end item 17d9c84b-3c58-4646-b43d-a96560764103 -->","topic":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b","topicId":"667146c4-e374-494f-a050-b8976e5e7056","topicName":"Immunizations - pneumococcal","slug":"immunizations-pneumococcal","aliases":["Pneumococcal immunizations"],"chapters":[{"id":"c2a8d969-5d35-5185-b666-883786b066c5","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"9db009c1-59ed-5d79-9446-33e54e1676c7","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"5459dd7c-ac40-5828-8bec-840fa7fca764","slug":"changes","fullItemName":"Changes"},{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update"}]},{"id":"95a44f6b-2987-5086-8656-ef21fcbbc28b","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"006db835-5d01-5085-a6e1-ee57f7ca41c8","slug":"goals","fullItemName":"Goals"},{"id":"29af8dc8-13e9-56c4-a041-b00bbf320b1e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7b32647-3434-5f3f-b8be-51203e3ebfee","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebc71bdc-4766-5946-bb16-121b9da544f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3daf6a12-bce0-53d4-a318-05cc49aab107","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4dce4bc5-1119-5c5d-9422-d275fc956a4e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"37c59838-49d0-51d5-8203-1eae848738c2","slug":"definition-of-pneumococcal-disease","fullItemName":"Definition of pneumococcal disease"},{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease"},{"id":"9da9e662-ccc4-5bc4-bae8-eb3f0ec80b19","slug":"risk-factors-for-pneumococcal-disease","fullItemName":"Risk Factors for pneumococcal disease"},{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization"}]},{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","slug":"management","fullItemName":"Management","subChapters":[{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age"},{"id":"8f83b7e0-d764-5bca-a03b-e549e24f402a","slug":"children-diagnosed-at-increased-risk-under-2-years-of-age","fullItemName":"Scenario: Children diagnosed at increased risk under 2 years of age"},{"id":"c9787edf-835f-54d9-9b86-b7c8695307ef","slug":"children-diagnosed-at-increased-risk-aged-2-5-years","fullItemName":"Scenario: Children diagnosed at increased risk aged 2-5 years"},{"id":"7f443a07-5081-5296-b56e-8b82550f8c52","slug":"children-over-5-years-of-age-adults-diagnosed-at-increased-risk","fullItemName":"Scenario: Children over 5 years of age and adults diagnosed at increased risk"}]},{"id":"f17e101b-7bea-59aa-9b9c-46924bbfdc2b","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"871f5861-588e-57ef-9521-0a81e77d4583","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"d0a50959-6448-5a18-8845-f75f5c40f388","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92b33782-e97b-565d-b432-b19376ecedbc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b1e27f9-71f0-5238-978b-5648b601e292","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b6c5d09-7606-5742-89c4-19fa3b671fd7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"037af05f-e510-5862-b316-4676f7c3a61e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04bd9328-ed11-5b9d-ba9a-06584ecd6f33","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b","topicId":"667146c4-e374-494f-a050-b8976e5e7056","topicName":"Immunizations - pneumococcal","slug":"immunizations-pneumococcal","aliases":["Pneumococcal immunizations"],"topicSummary":"Infection with the encapsulated bacteriumStreptococcus pneumoniaecauses pneumococcal infection, which may be invasive","lastRevised":"Last revised in January 2021","nextPlannedReviewBy":"2021-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2021-07","nextPlannedReviewByDisplay":"July 2021","specialities":[{"id":"1d6cc080-414a-5076-b33e-9cee585d5124","name":"Immunizations","slug":"immunizations"},{"id":"2454765b-1b2d-53fc-b288-17b66486f41a","name":"Preventative medicine","slug":"preventative-medicine"}],"chapters":[{"id":"c2a8d969-5d35-5185-b666-883786b066c5","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"9db009c1-59ed-5d79-9446-33e54e1676c7","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"5459dd7c-ac40-5828-8bec-840fa7fca764","slug":"changes","fullItemName":"Changes"},{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update"}]},{"id":"95a44f6b-2987-5086-8656-ef21fcbbc28b","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"006db835-5d01-5085-a6e1-ee57f7ca41c8","slug":"goals","fullItemName":"Goals"},{"id":"29af8dc8-13e9-56c4-a041-b00bbf320b1e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7b32647-3434-5f3f-b8be-51203e3ebfee","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebc71bdc-4766-5946-bb16-121b9da544f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3daf6a12-bce0-53d4-a318-05cc49aab107","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4dce4bc5-1119-5c5d-9422-d275fc956a4e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"37c59838-49d0-51d5-8203-1eae848738c2","slug":"definition-of-pneumococcal-disease","fullItemName":"Definition of pneumococcal disease"},{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease"},{"id":"9da9e662-ccc4-5bc4-bae8-eb3f0ec80b19","slug":"risk-factors-for-pneumococcal-disease","fullItemName":"Risk Factors for pneumococcal disease"},{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization"}]},{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","slug":"management","fullItemName":"Management","subChapters":[{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age"},{"id":"8f83b7e0-d764-5bca-a03b-e549e24f402a","slug":"children-diagnosed-at-increased-risk-under-2-years-of-age","fullItemName":"Scenario: Children diagnosed at increased risk under 2 years of age"},{"id":"c9787edf-835f-54d9-9b86-b7c8695307ef","slug":"children-diagnosed-at-increased-risk-aged-2-5-years","fullItemName":"Scenario: Children diagnosed at increased risk aged 2-5 years"},{"id":"7f443a07-5081-5296-b56e-8b82550f8c52","slug":"children-over-5-years-of-age-adults-diagnosed-at-increased-risk","fullItemName":"Scenario: Children over 5 years of age and adults diagnosed at increased risk"}]},{"id":"f17e101b-7bea-59aa-9b9c-46924bbfdc2b","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"871f5861-588e-57ef-9521-0a81e77d4583","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"d0a50959-6448-5a18-8845-f75f5c40f388","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92b33782-e97b-565d-b432-b19376ecedbc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b1e27f9-71f0-5238-978b-5648b601e292","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b6c5d09-7606-5742-89c4-19fa3b671fd7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"037af05f-e510-5862-b316-4676f7c3a61e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04bd9328-ed11-5b9d-ba9a-06584ecd6f33","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b"}},"staticQueryHashes":["3666801979"]}